ロード中...
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
Parkinson’s disease (PD) afflicts millions of people worldwide and leads to cognitive impairment or dementia in the majority of patients over time. Parkinson’s disease dementia (PDD) is characterized by deficits in attention, executive and visuospatial function, and memory. The clinical diagnostic c...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2656320/ https://ncbi.nlm.nih.gov/pubmed/19300613 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|